Farther Finance Advisors’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.68K | Buy |
181
+125
| +223% | +$2.54K | ﹤0.01% | 3478 |
|
|
2025
Q1 | $944 | Sell |
56
-64
| -53% | -$1.08K | ﹤0.01% | 3629 |
|
|
2024
Q4 | $3.03K | Sell |
120
-203
| -63% | -$5.13K | ﹤0.01% | 2857 |
|
|
2024
Q3 | $11K | Buy |
323
+3
| +0.9% | +$102 | ﹤0.01% | 2325 |
|
|
2024
Q2 | $12.5K | Buy |
320
+300
| +1,500% | +$11.7K | ﹤0.01% | 1990 |
|
|
2024
Q1 | $833 | Hold |
20
| – | – | ﹤0.01% | 2840 |
|
|
2023
Q4 | $793 | Buy |
20
+1
| +5% | +$40 | ﹤0.01% | 2818 |
|
|
2023
Q3 | $523 | Sell |
19
-299
| -94% | -$8.23K | ﹤0.01% | 2256 |
|
|
2023
Q2 | $10.8K | Sell |
318
-2,910
| -90% | -$98.7K | ﹤0.01% | 1170 |
|
|
2023
Q1 | $116K | Buy |
+3,228
| New | +$116K | 0.03% | 366 |
|